Danaher Q1 Revenues Increase 11 Percent

The conglomerate's Life Sciences and Diagnostics segment, which houses its AB Sciex business, saw sales rise 22 percent year over year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.